1. Introduction Genomics England (GEL) plays a pivotal role in advancing personalized medicine through large-scale genomic data analysis, primarily within the National Health Service (NHS) in the UK. By sequencing and analyzing genomes from patients with cancer and rare diseases, GEL aims to improve diagnosis, treatment strategies, and ultimately, patient outcomes. A critical area of […]